Kimberly Kuncl
Obstetrics · Nogales, AZNPI 1508850173
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.6% of the total across 108 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 29 manufacturers reported payments, led by AbbVie at 27.1% of the total. Reporting peaked in 2022 at $642 and has fallen 96.6% since, to $22 in 2024.
Across 108 payments — averaging $21.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$625
- Astellas Pharma US Inc$210
- Millicent US Inc$152
- Pfizer$151
- Hologic Sales And Service, LLC$144
- Mayne Pharma Commercial LLC$129
- plus $892 from 23 others
What the payments were for
- Food & beverage$2,27099%
- Education$321%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 33 | $625 |
| Astellas Pharma US Inc | 6 | $210 |
| Millicent US Inc | 2 | $152 |
| Pfizer | 8 | $151 |
| Hologic Sales And Service, LLC | 5 | $144 |
| Mayne Pharma Commercial LLC | 7 | $129 |
| Gynesonics, Inc. | 2 | $116 |
| Duchesnay USA Incorporated | 5 | $92 |
| Evofem Biosciences, Inc. | 5 | $76 |
| Exeltis, USA Inc. | 4 | $72 |
| Daiichi Sankyo Inc. | 4 | $65 |
| Shield Therapeutics Inc | 3 | $55 |
| Organon | 3 | $47 |
| Meditrina | 3 | $44 |
| Dysis Medical, Inc. | 1 | $42 |
| AMAG Pharmaceuticals, Inc. | 2 | $32 |
| Merck | 2 | $28 |
| Sumitomo Pharma America, Inc. | 1 | $27 |
| Lupin Inc. | 2 | $25 |
| Myovant Sciences Inc. | 1 | $21 |
| Coopersurgical, Inc. | 1 | $20 |
| Boston Scientific | 1 | $18 |
| Bayer | 1 | $18 |
| Therapeuticsmd, Inc. | 1 | $17 |
| Davol Inc. | 1 | $17 |
| Acessa Health Inc. | 1 | $16 |
| Mission Pharmacal Company | 1 | $16 |
| Optumhealth Care Solutions, LLC | 1 | $14 |
| Mylan Pharmaceuticals Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,302 in reported general payments places this provider in the 65th percentile of 23 obstetrics providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ValacyclovirValacyclovir Hcl | 19 | $580 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 24 | $513 |
| Norethindrone | 23 | $177 |
| Fluconazole | 14 | $34 |
Paid to pharmacies, not to this prescriber.
Other obstetrics in Nogales
- Jose DuranNogales$1K
- Jennifer Howell WelleTucson$33K
- Kevin HookerLake Havasu City$27K
- Katie GroffGlendale$4K
- Hannah TildenPhoenix$4K
- Chloe WoodPhoenix$3K
- Hetal ShahPhoenix$3K
- James FoltzPhoenix$2K
- Kristina SuntayScottsdale$2K
- Katharine ClarizioScottsdale$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.